Saniona AB (publ) (STO:SANION)
Sweden · Delayed Price · Currency is SEK 25.55
+0.95 (3.86%)
Feb 10, 2026, 5:29 PM CET
Saniona AB Market Cap
Saniona AB has a market cap or net worth of 3.4 billion as of February 10, 2026. Its market cap has increased by 377.43% in one year.
Market Cap
3.40B
Enterprise Value
2.72B
Revenue
743.21M
Ranking
n/a
PE Ratio
5.40
Stock Price
25.55
Market Cap Chart
Since April 22, 2014, Saniona AB's market cap has increased from 71.49M to 3.40B, an increase of 4,649.45%. That is a compound annual growth rate of 38.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 3.40B | 16.04% |
| Dec 30, 2025 | 2.93B | 223.43% |
| Dec 30, 2024 | 904.76M | 251.84% |
| Dec 29, 2023 | 257.15M | 34.48% |
| Dec 30, 2022 | 191.21M | -65.37% |
| Dec 30, 2021 | 552.11M | -57.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.69B |
| Vicore Pharma Holding AB | 2.91B |
| Flerie AB | 2.77B |
| Diamyd Medical AB | 2.25B |
| Egetis Therapeutics AB | 1.97B |
| BioInvent International AB | 1.71B |
| Genovis AB (publ.) | 1.35B |
| Cantargia AB | 1.32B |